Trials / Completed
CompletedNCT00330044
Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer
A Phase I Study of Premetrexed (Alimta) and Carboplatin and Radiation Therapy in Patients With Inoperable Non Small Cell Lung Cancer.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the safety of Alimta when used with chemoradiation in inoperable non small cell lung cancer
Detailed description
To determine the maximal tolerated dose (MTD) and toxicities of Pemetrexed (Alimta) when administered concurrently with carboplatin and thoracic radiation therapy. To determine, qualitatively, the occurrence of local tumor responses identified with this regimen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Premetrexed (Alimta) | |
| DRUG | Carboplatin |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2009-08-01
- Completion
- 2009-10-01
- First posted
- 2006-05-25
- Last updated
- 2025-05-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00330044. Inclusion in this directory is not an endorsement.